EPD1504: a novel μ-opioid receptor partial agonist attenuates obsessive–compulsive disorder (OCD)-like behaviors

Overview of attention for article published in Frontiers in Psychiatry, June 2023

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (59th percentile)
High Attention Score compared to outputs of the same age and source (80th percentile)

Mentioned by

twitter: 5 X users

Readers on

mendeley: 5 Mendeley

Summary X

So far, Altmetric has seen 5 X posts from 5 X users, with an upper bound of 16,372 followers.

EPD1504: a novel μ-opioid receptor partial agonist attenuates obsessive-compulsive disorder (OCD)-like behaviors https://t.co/Ww0IEf6kb9

19 Jul 2023

Reply Repost Favourite

A μ-opioid r. partial agonist (EPD1540) and buprenorphine rapidly ameliorate symptoms in TR-OCD by occupying 20% of MORs in the CNS and without impairing either locomotor activity or respiration under normoxic or hypercapnic conditions https://t.co/2QftZTQ

11 Jul 2023

Reply Repost Favourite

RT @FrontPsychiatry: New Research: EPD1504: a novel μ-opioid receptor partial agonist attenuates obsessive–compulsive disorder (OCD)-like b…

30 Jun 2023

Reply Repost Favourite

RT @FrontPsychiatry: New Research: EPD1504: a novel μ-opioid receptor partial agonist attenuates obsessive–compulsive disorder (OCD)-like b…

30 Jun 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.